INVOKAMET

Janssen Pharmaceuticals, Inc.🇺🇸 United States

FDA Page

Effective Date: Aug 24, 2026
Approval ID: 6868666b-c25e-40d1-9d1f-306bbe9390c1
Products: 8 registered
Version: 32

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014

Quick Stats

Total Products8

Labelers2

Label Sections27

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.